130 related articles for article (PubMed ID: 36473713)
21. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore modeling and molecular dynamics approach to identify putative DNA Gyrase B inhibitors for resistant tuberculosis.
Kashyap A; Singh PK; Satpati S; Verma H; Silakari O
J Cell Biochem; 2019 Mar; 120(3):3149-3159. PubMed ID: 30191589
[TBL] [Abstract][Full Text] [Related]
23. Structure based design and synthesis of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives as novel bacterial DNA-gyrase inhibitors: In-vitro, In-vivo, In-silico and SAR studies.
Saleh MA; Elmaaty AA; El Saeed HS; Saleh MM; Salah M; Ezz Eldin RR
Bioorg Chem; 2022 Dec; 129():106186. PubMed ID: 36215786
[TBL] [Abstract][Full Text] [Related]
24. Molecular Dynamics Simulations of Quinolone Resistance-Associated T86I and P104S Mutations in Campylobacter jejuni gyrA: Unraveling Structural Repercussions.
Mehla K; Ramana J
Microb Drug Resist; 2018 Apr; 24(3):232-243. PubMed ID: 28759328
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
[TBL] [Abstract][Full Text] [Related]
26. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
[TBL] [Abstract][Full Text] [Related]
27. De novo design of novel DNA-gyrase inhibitors based on 2D molecular fingerprints.
Huang Z; Lin K; You Q
Bioorg Med Chem Lett; 2013 Jul; 23(14):4166-71. PubMed ID: 23743285
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
[TBL] [Abstract][Full Text] [Related]
29. In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.
Kamsri P; Punkvang A; Hannongbua S; Suttisintong K; Kittakoop P; Spencer J; Mulholland AJ; Pungpo P
SAR QSAR Environ Res; 2019 Nov; 30(11):775-800. PubMed ID: 31607177
[No Abstract] [Full Text] [Related]
30. Thermodynamic computational approach to capture molecular recognition in the binding of different inhibitors to the DNA gyrase B subunit from Escherichia coli.
Saíz-Urra L; Pérez MÁ; Froeyen M
J Mol Model; 2013 Aug; 19(8):3187-200. PubMed ID: 23625033
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase.
Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH
Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364
[TBL] [Abstract][Full Text] [Related]
32. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
Mehla K; Ramana J
OMICS; 2016 Nov; 20(11):635-644. PubMed ID: 27753544
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
34. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
Ponnusamy T; Alagumuthu M; Thamaraiselvi S
Bioorg Med Chem; 2018 Jul; 26(12):3438-3452. PubMed ID: 29803359
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations.
Maharaj Y; Soliman ME
Chem Biol Drug Des; 2013 Aug; 82(2):205-15. PubMed ID: 23614896
[TBL] [Abstract][Full Text] [Related]
36. New 1,2,4-oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity.
Frejat FOA; Cao Y; Wang L; Zhai H; Abdelazeem AH; Gomaa HAM; Youssif BGM; Wu C
Arch Pharm (Weinheim); 2022 Jul; 355(7):e2100516. PubMed ID: 35363388
[TBL] [Abstract][Full Text] [Related]
37. Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments.
Kolarič A; Novak D; Weiss M; Hrast M; Zdovc I; Anderluh M; Minovski N
Future Med Chem; 2019 May; 11(9):935-945. PubMed ID: 31140866
[No Abstract] [Full Text] [Related]
38. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
[TBL] [Abstract][Full Text] [Related]
39. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel Pseudomonas aeruginosa DNA gyrase B inhibitors.
Jogula S; Krishna VS; Meda N; Balraju V; Sriram D
Bioorg Chem; 2020 Jul; 100():103905. PubMed ID: 32388436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
